Hyperviscosity syndrome in IgE myeloma.

Abstract

impair mineralisation may limit the hypocalcaemic effect. The ease with which diphosphonates may be used and the absence of appreciable side effects4 make this an attractive treatment not only for immobilisation hypercalcaemia but also for the more commonly observed hypercalciuria and bone loss.